{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:18:22Z","timestamp":1782587902356,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.pedhc.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T12:19:45Z","timestamp":1360930785000},"page":"135-144","source":"Crossref","is-referenced-by-count":22,"title":["\u201cHow High Do They Look?\u201d: Identification and Treatment of Common Ingestions in Adolescents"],"prefix":"10.1016","volume":"27","author":[{"given":"Teri Moser","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pedhc.2012.12.002_bib1","first-page":"16","article-title":"Psychoactive herb use and youth: A closer look at salvia divinorum","volume":"49","author":"Ahern","year":"2011","journal-title":"Journal of Psychosocial Nursing"},{"key":"10.1016\/j.pedhc.2012.12.002_bib2","unstructured":"American Association of Poison Control Centers. (2012). Synthetic marijuana. Retrieved from www.aapcc.org\/alerts\/synthetic-marijuana\/"},{"key":"10.1016\/j.pedhc.2012.12.002_bib3","unstructured":"Anderson, I. B. (2007). Dextromethorphan abuse in adolescence: A rising trend. California Poison Control System. Retrieved from www.csam-asam.org\/pdf\/misc\/DXM_CSAM_9_07.ppt"},{"key":"10.1016\/j.pedhc.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1196\/annals.1432.003","article-title":"Dextromethorphan an emerging drug of abuse","volume":"1139","author":"Banken","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10.1016\/j.pedhc.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpedi.160.12.1217","article-title":"Dextromethorphan abuse in adolescence","volume":"160","author":"Bryner","year":"2006","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"key":"10.1016\/j.pedhc.2012.12.002_bib6","unstructured":"Buck, M. L. (2008). Caffeine citrate for the treatment of apnea of\u00a0prematurity. Pediatric Pharmacotherapy: A Monthly Newsletter for Health Care Professionals from the University of\u00a0Virginia Children's Hospital, 14(6), 1\u20134. Retrieved from http:\/\/www.medicine.virginia.edu\/clinical\/departments\/pediatrics\/education\/pharm-news\/2006-2010\/200806.pdf"},{"issue":"11","key":"10.1016\/j.pedhc.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0091270005280755","article-title":"The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans","volume":"45","author":"Casner","year":"2005","journal-title":"Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.pedhc.2012.12.002_bib8","first-page":"1","article-title":"Youth risk behavior surveillance\u2014United States, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR"},{"issue":"6","key":"10.1016\/j.pedhc.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/15563650701606443","article-title":"Dextromethorphan poisoning: An evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Chyka","year":"2007","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.pedhc.2012.12.002_bib10","article-title":"FDA: 5 death reports for Monster Energy Drink","author":"DeNoon","year":"2012","journal-title":"WebMD Health News"},{"key":"10.1016\/j.pedhc.2012.12.002_bib11","unstructured":"Drug Abuse Warning Network. (2011). Emergency department visits involving energy drinks. Retrieved from http:\/\/www.samhsa.gov\/data\/2k11\/WEB_DAWN_089\/WEB_DAWN_089.htm"},{"key":"10.1016\/j.pedhc.2012.12.002_bib12","unstructured":"eHow. (2012). How to use salt to separate Purell. Retrieved from http:\/\/www.ehow.co.uk\/how_7504498_use-salt-separate-purell.html"},{"key":"10.1016\/j.pedhc.2012.12.002_bib13","unstructured":"Erowid.org. (2009). 2C-E. In A. Shulgin & A. Shulgin, Pihkal: A chemical love story. Retrieved from http:\/\/www.erowid.org\/library\/books_online\/pihkal\/pihkal024.shtml"},{"key":"10.1016\/j.pedhc.2012.12.002_bib14","unstructured":"Hahn, I. H. (2011). MDMA toxicity. Medscape Drugs, Diseases, & Procedures. Retrieved from http:\/\/emedicine.medscape.com\/article\/821572-overview"},{"issue":"10","key":"10.1016\/j.pedhc.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2011.11010176","article-title":"Psychosis associated with synthetic cannabinoid agonists: A case series","volume":"168","author":"Hurst","year":"2011","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.pedhc.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3949\/ccjm.79a.11147","article-title":"Synthetic legal intoxicating drugs: The emerging \u201cincense\u201d and \u201cbath salt\u201d phenomenon","volume":"79","author":"Jerry","year":"2012","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pedhc.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7205\/MILMED-D-10-00356","article-title":"Spice: A legal marijuana equivalent","volume":"176","author":"Johnson","year":"2011","journal-title":"Military Medicine"},{"key":"10.1016\/j.pedhc.2012.12.002_bib18","series-title":"Monitoring the Future national survey results on drug use, 1975-2011. Volume I: Secondary school students","author":"Johnston","year":"2012"},{"issue":"9","key":"10.1016\/j.pedhc.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7205\/MILMED-D-12-00180","article-title":"Spice, bath salts, and the U.S. military: The emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces","volume":"177","author":"Loeffler","year":"2012","journal-title":"Military Medicine"},{"key":"10.1016\/j.pedhc.2012.12.002_bib52","unstructured":"Meier, BM (2012, November 14). Caffeinated drink cited in reports of 13 deaths. The New York Times. Retrieved from http:\/\/www.nytimes.com\/2012\/11\/15\/business\/5-hour-energy-is-cited-in-13-death-reports.html"},{"issue":"9","key":"10.1016\/j.pedhc.2012.12.002_bib20","first-page":"23","article-title":"\u201cSpice\u201d and \u201cK2\u201d: New drugs of abuse now on the market","volume":"42","author":"Munsey","year":"2011","journal-title":"American Psychological Association Monitor on Psychology"},{"key":"10.1016\/j.pedhc.2012.12.002_bib21","unstructured":"National Institute on Drug Abuse. (2006). MDMA (Ecstasy) abuse (National Institute on Drug Abuse Research Report Series, NIH Publication No. 06-4728). Retrieved from http:\/\/www.drugabuse.gov\/sites\/default\/files\/rrmdma_0.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib22","unstructured":"National Institute on Drug Abuse. (2011). Drug facts: Salvia. Retrieved from http:\/\/www.drugabuse.gov\/sites\/default\/files\/salvia_0.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib23","unstructured":"National Institute on Drug Abuse. (2012a). Drug facts: High school and youth trends. Retrieved from http:\/\/www.drugabuse.gov\/publications\/drugfacts\/high-school-youth-trends"},{"key":"10.1016\/j.pedhc.2012.12.002_bib24","unstructured":"National Institute on Drug Abuse. (2012b). Drug facts: Prescription and over-the-counter medications. Retrieved from http:\/\/www.drugabuse.gov\/publicatiRetons\/drugfacts\/prescription-over-counter-medications"},{"key":"10.1016\/j.pedhc.2012.12.002_bib25","unstructured":"National Institute on Drug Abuse. (2012c). Drug facts: Spice (synthetic marijuana). Retrieved from http:\/\/www.drugabuse.gov\/publications\/drugfacts\/spice-synthetic-marijuana"},{"key":"10.1016\/j.pedhc.2012.12.002_bib26","unstructured":"Nordqvist, C. (2012). Teens getting drunk on liquid hand sanitizers. Medical News Today. Retrieved from http:\/\/www.medicalnewstoday.com\/articles\/244536.php"},{"issue":"6","key":"10.1016\/j.pedhc.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jen.2010.07.018","article-title":"Herbal hallucinations: Common abuse situations seen in the emergency department","volume":"36","author":"Oether","year":"2010","journal-title":"Journal of Emergency Nursing"},{"key":"10.1016\/j.pedhc.2012.12.002_bib28","unstructured":"Oregon Public Health Division. (2012a). Risky business: Dangerous drugs and tainted tattoos. CD Summary, 61(7), 1\u20132. Retrieved from http:\/\/public.health.oregon.gov\/DiseasesConditions\/CommunicableDisease\/CDSummaryNewsletter\/Documents\/2012\/ohd6121.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib29","unstructured":"Oregon Public Health Division. (2012b). You can't always get what you want: Designer drugs, methemoglobinemia and the internet. CD Summary, 61(7), 1\u20132. Retrieved from http:\/\/public.health.oregon.gov\/DiseasesConditions\/CommunicableDisease\/CDSummaryNewsletter\/Documents\/2012\/ohd6107.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib30","doi-asserted-by":"crossref","unstructured":"Sacks, J., Ray, J., Williams, S., & Opatowsky, M. J. (2012). Fatal toxic leukoencephalopathy secondary to overdose of a new psychoactive designer drug 2C-E (\u201cEuropa\u201d). Baylor University Medical Center Proceedings, 25(4), 374\u2013376. Retrieved from http:\/\/www.baylorhealth.edu\/Documents\/BUMC%20Proceedings\/2012%20Vol%2025\/No.%204\/25_4_Sacks.pdf","DOI":"10.1080\/08998280.2012.11928883"},{"key":"10.1016\/j.pedhc.2012.12.002_bib31","unstructured":"Salomone, J. A. (2011). Hallucinogen toxicity. Medscape Reference: Drugs, Diseases & Procedures. Retrieved from http:\/\/emedicine.medscape.com\/article\/814848-overview"},{"issue":"7","key":"10.1016\/j.pedhc.2012.12.002_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/000992280504400702","article-title":"Adolescent abuse of dextromethorphan","volume":"44","author":"Schwartz","year":"2005","journal-title":"Clinical Pediatrics"},{"key":"10.1016\/j.pedhc.2012.12.002_bib33","unstructured":"The Third Plateau. (1998). So you want to try DXM? A beginner's guide to DXM. Retrieved from http:\/\/dxm.darkridge.com\/text\/beginners.html"},{"key":"10.1016\/j.pedhc.2012.12.002_bib34","unstructured":"United Nations Office on Drugs and Crime. (2011). Synthetic cannabinoids in herbal products (United Nations document No. SCITEC\/24). Retrieved from http:\/\/www.unodc.org\/documents\/scientific\/Synthetic_Cannabinoids.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib35","unstructured":"U.S. Department of Justice Drug Enforcement Administration. (n.d.) Drug fact sheet: Bath salts or designer cathinones (synthetic stimulants). Retrieved from http:\/\/www.justice.gov\/dea\/druginfo\/drug_data_sheets\/Bath_Salts.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib36","unstructured":"U.S. Department of Justice Drug Enforcement Administration. (n.d.)\u00a0Drug fact sheet: Dextromethorphan (DXM). Retrieved from http:\/\/www.justice.gov\/dea\/druginfo\/drug_data_sheets\/Detromethorphan.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib37","unstructured":"U.S. Department of Justice Drug Enforcement Administration, Office of Diversion Control. (2011). 3,4-Methylenedioxymethamphetamine. Retrieved from http:\/\/www.deadiversion.usdoj.gov\/drugs_concern\/mdma\/mdma.pdf"},{"key":"10.1016\/j.pedhc.2012.12.002_bib38","unstructured":"U.S. Department of Justice Drug Enforcement Administration, Office of Diversion Control (2012a). Drugs and chemicals of concern: Spice cannabinoid. Retrieved from http:\/\/www.deadiversion.usdoj.gov\/drugs_concern\/spice\/index.html"},{"key":"10.1016\/j.pedhc.2012.12.002_bib39","unstructured":"U.S. Department of Justice Drug Enforcement Administration, Office of Diversion Control. (2012b). Salvia divinorum and salvinorin A. Retrieved from http:\/\/www.deadiversion.usdoj.gov\/drugs_concern\/salvia_d.pdf"},{"issue":"2","key":"10.1016\/j.pedhc.2012.12.002_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MOP.0b013e3283506827","article-title":"Toxicity of energy drinks","volume":"24","author":"Wolk","year":"2012","journal-title":"Current Opinion In Pediatrics"},{"issue":"11","key":"10.1016\/j.pedhc.2012.12.002_bib41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphisms of human cytochrome P450 2D6 and its clinical significance: Part 1","volume":"48","author":"Zhou","year":"2009","journal-title":"Clinical Pharmacokinetics"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089152451200291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089152451200291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T03:11:20Z","timestamp":1714965080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089152451200291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S089152451200291X"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2012.12.002","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}